MSMEDA, Reefy sign EGP300m microfinance deal    Sanofi introduces new multiple myeloma treatment to Egyptian market    Central Bank of Egypt, Medical Emergencies, Genetic and Rare Diseases Fund renew deal for 3 years    Gold prices dip on Tuesday    Oil prices fall on Tuesday    Egypt begins trial operations at Red Sea Container Terminal as first vessel docks at Sokhna Port    Egypt, Saudi FMs discuss Gaza, Sudan and preparations for Supreme Coordination Council    Egypt moves to roll out 'green label' for plastic products to boost circular economy    As Kyiv weighs neutrality, Kremlin eyes a 'cornerstone' for peace while Europe warns of trap    GAFI witnesses first Polish investment agreement in Egypt's frozen food sector    Egypt, Italy's Eni discuss healthcare partnership to operate two hospitals    'Friends become enemies': Trump's new strategy fractures European unity    Egypt's SPNEX Satellite successfully enters orbit    Madinaty Golf Club hosts charity tournament for Alzheimer's awareness    Egypt unveils restored colossal statues of King Amenhotep III at Luxor mortuary temple    Egyptian Golf Federation appoints Stuart Clayton as technical director    4th Egyptian Women Summit kicks off with focus on STEM, AI    Egypt's PM reviews major healthcare expansion plan with Nile Medical City    UNESCO adds Egyptian Koshari to intangible cultural heritage list    UNESCO adds Egypt's national dish Koshary to intangible cultural heritage list    Egypt calls for inclusive Nile Basin dialogue, warns against 'hostile rhetoric'    Egypt recovers two ancient artefacts from Belgium    Egypt, Saudi nuclear authorities sign MoU to boost cooperation on nuclear safety    Giza master plan targets major hotel expansion to match Grand Egyptian Museum launch    Australia returns 17 rare ancient Egyptian artefacts    China invites Egypt to join African duty-free export scheme    Egypt calls for stronger Africa-Europe partnership at Luanda summit    Egypt begins 2nd round of parliamentary elections with 34.6m eligible voters    Egypt warns of erratic Ethiopian dam operations after sharp swings in Blue Nile flows    Egypt scraps parliamentary election results in 19 districts over violations    Egypt golf team reclaims Arab standing with silver; Omar Hisham Talaat congratulates team    Egypt launches Red Sea Open to boost tourism, international profile    Sisi expands national support fund to include diplomats who died on duty    Egypt's PM reviews efforts to remove Nile River encroachments    Egypt resolves dispute between top African sports bodies ahead of 2027 African Games    Germany among EU's priciest labour markets – official data    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Pfizer, BioNTech may get $2 billion from US for 100 million doses of potential coronavirus vaccine
aya salah Published in Amwal Al Ghad on 23 - 07 - 2020

The US government will pay $1.95 billion for Pfizer and BioNTech when the companies manufacture potential COVID-19 vaccine, if Pfizer obtains approval or emergency use authorization from the Food and Drug Administration. The government can also acquire up to 500 million additional doses of the vaccine under the agreement.
The agreement with Pfizer and BioNTech is part of the US government's Operation Warp Speed program goal to begin delivering 300 million doses of a vaccine for COVID-19 in 2021.
Shares of both Pfizer and BioNTech increased; Pfizer jumped as much as 6 percent, while BioNTech rose nearly 8 percent afterr signing a $2 billion deal to supply their experimental coronavirus vaccine

Clic here to read the story from its source.